This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignees: Janssen Sciences Ireland Uc, Viiv Healthcare Company. Active years: 2024.
Company Filing History:
1 out of 111 
1 out of 42 
Years Active: 2024
Title: Thomas Laughery: Innovator in HIV Treatment
Introduction
Thomas Laughery is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of medicine, particularly in the treatment of human immunodeficiency virus (HIV). His innovative approaches have the potential to improve the quality of life for patients living with HIV.
Latest Patents
Thomas Laughery holds 1 patent for his invention titled "Combination and uses and treatments thereof." This patent outlines methods for treating or preventing HIV-1 and HIV-2 in virologically suppressed patients. The invention involves switching patients from a treatment regimen that includes at least three antiretroviral agents to one that comprises only two agents. Specifically, the two-agent regimen consists of dolutegravir and rilpivirine, along with at least one pharmaceutically acceptable excipient, diluent, or carrier. Additionally, the patent describes a multilayer tablet containing dolutegravir or its pharmaceutically acceptable salt and rilpivirine or its pharmaceutically acceptable salt.
Career Highlights
Throughout his career, Thomas Laughery has worked with prominent companies in the pharmaceutical industry, including ViiV Healthcare and Janssen Sciences Ireland UC. His work has focused on developing effective treatments for HIV, showcasing his commitment to advancing medical science.
Collaborations
Thomas has collaborated with esteemed colleagues such as Kenneth Churchill Campbell and Urbain Alfons C Delaet. These partnerships have contributed to the development of innovative solutions in the field of HIV treatment.
Conclusion
Thomas Laughery's contributions to HIV treatment through his patent and collaborations highlight his dedication to improving patient outcomes. His work exemplifies the impact of innovation in the medical field.